BMY - Bristol-Myers Squibb Company

NYSE - NYSE Delayed price. Currency in USD
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
6,327,000
6,327,000
6,994,000
-9,015,000
3,439,000
Depreciation & amortisation
10,276,000
10,276,000
10,686,000
10,380,000
1,746,000
Deferred income taxes
-2,738,000
-2,738,000
-1,393,000
983,000
-924,000
Stock-based compensation
457,000
457,000
583,000
779,000
441,000
Change in working capital
-2,229,000
-2,229,000
-1,253,000
983,000
3,065,000
Inventory
-69,000
-69,000
13,000
2,672,000
463,000
Accounts payable
109,000
109,000
245,000
188,000
229,000
Other working capital
11,948,000
11,948,000
15,234,000
13,299,000
7,231,000
Other non-cash items
1,038,000
1,038,000
-400,000
9,504,000
501,000
Net cash provided by operating activities
13,066,000
13,066,000
16,207,000
14,052,000
8,067,000
Cash flows from investing activities
Investments in property, plant and equipment
-1,118,000
-1,118,000
-973,000
-753,000
-836,000
Acquisitions, net
-4,286,000
-4,286,000
-1,610,000
-13,084,000
-24,634,000
Purchases of investments
-3,592,000
-3,592,000
-5,478,000
-4,172,000
-3,961,000
Sales/maturities of investments
6,629,000
6,629,000
6,775,000
6,280,000
3,809,000
Net cash used for investing activities
-1,062,000
-1,062,000
-538,000
-10,859,000
-9,770,000
Cash flows from financing activities
Debt repayment
-11,431,000
-11,431,000
-6,022,000
-2,750,000
-9,256,000
Common stock repurchased
-8,001,000
-8,001,000
-6,287,000
-1,546,000
-7,300,000
Dividends paid
-4,634,000
-4,634,000
-4,396,000
-4,075,000
-2,679,000
Other financing activities
-
-
641,000
542,000
-53,000
Net cash used provided by (used for) financing activities
-16,962,000
-16,962,000
-16,224,000
-1,151,000
7,621,000
Net change in cash
-4,991,000
-4,991,000
-657,000
2,153,000
5,909,000
Cash at beginning of period
14,316,000
14,316,000
14,973,000
12,820,000
6,911,000
Cash at end of period
9,325,000
9,325,000
14,316,000
14,973,000
12,820,000
Free cash flow
Operating cash flow
13,066,000
13,066,000
16,207,000
14,052,000
8,067,000
Capital expenditure
-1,118,000
-1,118,000
-973,000
-753,000
-836,000
Free cash flow
11,948,000
11,948,000
15,234,000
13,299,000
7,231,000